Gapping down
In reaction to disappointing earnings/guidance:
- TER -10.4%, EW -8.5%, BABY -8.2%, BEDU -6.7%, MRCY -4.5%, DLB -4.3%, GLPI -4%, MKL -3.2%, TRVG -2.8%, WYNN -2.6%, CVE -2.6%, CMCSA -2.5%, MKSI -1.9%, LYG -1.9%, OC -1.6%, STO -1%, LUV -0.9%, NOC -0.7%, AMGN -0.5%
Other news:
- MNLO -9.5% (discloses that its partners for development and commercialization of serlopitant in Japan have informed that they have decided to halt the recently initiated Japanese Phase 2 clinical trial of serlopitant)
- SGMO -5.9% (commenced an underwritten public offering of $200.0 mln of shares of its common stock)
- ABMD -1% (comments on CMS proposed rule for the inpatient prospective payment system)
Analyst comments:
- N/A.